Dr. Chen Lee MBO management paradigm at ESMO Gynecological Cancers @StephanieLheur5 @NazlinJivraj @myESMO

A great practical presentation on Mirvetuximab in patients with platinum resistant ovarian cancers by my dear colleague🌟 @AinhoaMada @myESMO

EUROCAN what a great example on what collaboration can achieve to improve management decisions for patients with rare gynecological cancers @myESMO #ESMOgynecologicalcancers2024 instagram.com/p/C8eLUueNqG4/…

🌟🌟🌟Exceptional educational discussion this morning in ESMO GYNE @myESMO #Florence The evolving la escape in endometrial cancer from staging to therapy. FIGO 2023, ADCs are approaching 💉 cslide.ctimeetingtech.com/gy…

Congrats Ainhoa! 🎉👏Outstanding PhD brilliantly presented! It was a real pleasure and honour to co-direct your thesis! Looking forward to continue working together!

Incredible presentation by Dr. Lheureux at ASCO 2024!

Very impressive results! Neoadjuvant Immunotherapy in Locally Advanced Mismatch Repair–Deficient Colon Cancer | New England Journal of Medicine ⁦@NEJM⁩ nejm.org/doi/full/10.1056/NE…

📣 Do not miss this great e-Session on the newest data on DDR targeting agent @ESOncology

Apply for the CRIS Cancer-Princess Margaret drug development fellowship @criscancer @pmcancercentre - great opportunity for those with interests in phase I trials and translational research criscancer.org/es/cris-princ…

How beautiful is to remember our own humanity in a world of institutional insanity. This is the only way to remember what really is meaningful 👨‍👩‍👧‍👦🥇🌟🗺️

Such an honor to be part of this great event! Thanks @myESMO for the opportunity.

A refreshing reflection on how we need to be change cancer categorization to allow treatment access. But how are we going to get equity in molecular cancer testing? @YvonneBombard Forget lung, breast or prostate cancer: why tumour naming needs to change nature.com/articles/d41586-0…

New germline genetic testing guidelines: All women with breast cancer diagnosis under the age of 65 should be offered germline genetic testing. They don’t need to meet any additional criteria. Thank you @ASCO for the opportunity to draft these guidelines. ascopubs.org/doi/full/10.120…

One of the most important trials presented and published in 2023

Correct! Anthracyclines were originally discovered in Italy approximately 70 years ago by a company named Farmitalia. A member of the team went on expedition to Castel del Monte, in Puglia, in which soil he identified a strain of Streptomyces producing a substance with antitumoral proprieties: he called it “Daunomycin”, from the tribes of “Daunii” that used to live in Puglia during the Bronze Age. The first trials with daunomycin were conducted at the NCI of Milan and at MSKCC, describing the first clinical responses. Meanwhile, the team at Farmitalia kept working on the molecule, developing an even more potent analogue. They called it “Adriamycin”, from the Adriatic Sea that bathes the shores of Puglia, and that can be easily reached from Castel del Monte, where everything started. More info here: journals.sagepub.com/doi/10.…

Happy to present at #ESMO23 the results of #MBOT the first app 📱 for Ambulatory Malignant Bowel Obstruction management in #gynecancer @pmcancercentre Thanks to @ConquerCancerFd for making it possible through a #YIA grant

I❤️❤️being a thoracic oncologist: while our GI colleagues still struggle with folfox and folfiri 🥱we have numerous new exciting ⚡️& effective Tx 🔥 ADCs will soon be a part of our new routine so register to this webinar by @IASLC with @danieltanmd Ben Levy and Toni Wozniak

Final results of DESTINY-CRC01 investigating trastuzumab deruxtecan in HER2 #CRC @NatureComms doi.org/10.1038/s41467-023-3… 👉ORR 45.3%, mPFS 6.9, mOS 15.5 and DoR 7.0 mo in IHC 3 /IHC 2 ,ISH 👉Pneumonitis 9.3%, TEAEs ≥3 65% 👉sig. activity independent of prior 🎯💊 @myESMO @OncoAlert

Every CRC patient should be HER2 tested🧪. Final results of DESTINY-CRC01 investigating trastuzumab deruxtecan in patients with HER2-expressing metastatic colorectal cancer | Nature Communications nature.com/articles/s41467-0…

I’m pretty certain I’m alive because I am white & was born into a middle class family in the US. Dr Upal Basu Roy & I often say while I/everyone deserves quality care, it’s hard to balance when much of what we advocate for will only reach ppl like me ‘a person of privilege’ 😔